title: Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials.
abstract: As the number of new antibiotics that reach the market is decreasing and the demand for them is rising, alternative sources of novel antimicrobials are needed. Lantibiotics are potent peptide antimicrobials that are ribosomally synthesized and stabilized by post-translationally introduced lanthionine rings. Their ribosomal synthesis and enzymatic modifications provide excellent opportunities to design and engineer a large variety of novel antimicrobial compounds. The research conducted in this area demonstrates that the modularity present in both the peptidic rings as well as in the combination of promiscuous modification enzymes can be exploited to further increase the diversity of lantibiotics. Various approaches, where the modifying enzymes and corresponding leader peptides are decoupled from their natural core peptide and integrated in designed plug-and-play production systems, enable the production of modified peptides that are either derived from vast genomic data or designed using functional parts from a wide diversity of core peptides. These approaches constitute a powerful discovery platform to develop novel antimicrobials with high therapeutic potential.
authors: Department of Molecular Genetics, University of Groningen, Nijenborgh 7, 9747AG Groningen, the Netherlands.
authors: Manuel
authors: M
authors: Montalbán-López
authors: Department of Molecular Genetics, University of Groningen, Nijenborgh 7, 9747AG Groningen, the Netherlands.
authors: Auke J
authors: AJ
authors: van Heel
authors: Department of Molecular Genetics, University of Groningen, Nijenborgh 7, 9747AG Groningen, the Netherlands o.p.kuipers@rug.nl.
authors: Oscar P
authors: OP
authors: Kuipers
mesh_terms: D000890:Anti-Infective Agents; D001430:Bacteriocins / Q000096:biosynthesis*; D057005:Bioengineering; D015195:Drug Design
chemical_list: D000890:Anti-Infective Agents; D001430:Bacteriocins
keywords: PTM: post-translational modifications; RiPPs: ribosomally produced and post-translationally modified peptides; antimicrobial; lantibiotics